CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-09-22 | Satter Muneer A 10% owner | Purchase | +150,000 | $15.00 | $2.3M | 1,771,688 |
| 2014-09-22 | Satter Muneer A 10% owner | Conversion · Series D-1 Preferred Stock | −4,577,315 | 0 | ||
| 2014-09-22 | Satter Muneer A 10% owner | Conversion · Series D-2 Preferred Stock | −457,728 | 0 | ||
| 2014-09-22 | Satter Muneer A 10% owner | Conversion · Series D-3 Preferred Stock | −3,931,085 | 0 | ||
| 2014-09-22 | Satter Muneer A 10% owner | Conversion · Series E Preferred Stock | −8,013,003 | 0 | ||
| 2014-09-22 | Apple Tree Partners II - Annex, L.P. Director | Conversion | +3,330,938 | 3,330,938 | ||
| 2014-09-22 | Apple Tree Partners II - Annex, L.P. Director | Purchase | +237,500 | $15.00 | $3.6M | 3,568,438 |
| 2014-09-22 | Apple Tree Partners II - Annex, L.P. Director | Conversion · Series D-3 Preferred Stock | −10,675,613 | 0 | ||
| 2014-09-22 | Apple Tree Partners II - Annex, L.P. Director | Conversion · Series E Preferred Stock | −24,199,308 | 0 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion | +4,218,632 | 4,218,641 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion · Series A Preferred Stock | −4,500,000 | 0 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion · Series B-1 Preferred Stock | −798,067 | 0 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion · Series B-2 Preferred Stock | −644,786 | 0 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion · Series C Preferred Stock | −14,604,833 | 0 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion · Series D-1 Preferred Stock | −8,711,335 | 0 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion · Series D-2 Preferred Stock | −1,539,643 | 0 | ||
| 2014-09-22 | APPLE TREE PARTNERS II LP Director | Conversion · Series D-3 Preferred Stock | −13,370,422 | 0 | ||
| 2014-09-22 | Harrison Seth Loring Director | Conversion | +7,549,570 | 7,549,579 | ||
| 2014-09-22 | Harrison Seth Loring Director | Purchase | +362,500 | $15.00 | $5.4M | 7,912,079 |
| 2014-09-22 | Harrison Seth Loring Director | Conversion · Series A Preferred Stock | −4,500,000 | 0 |
Page 14 of 15 · 300 trades